We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
- Authors
Cocito, Dario; Ciaramitaro, Palma; Isoardo, Gianluca; Barbero, Pierangelo; Migliaretti, Giuseppe; Pipieri, Antonio; Proto, Giuliana; Quadri, Roberto; Bergamasco, Bruno; Durelli, Luca
- Abstract
The authors investigated the impact of IVIg as first line treatment of diabetic patients suffering from chronic inflammatory demyelinating polyneuropathy (CIDP) concomitant with distal symmetric axonal polyneuropathy. Nine patients with these clinical and electrophysiological features were treated with IVIg (0.4 g/Kg/day for 5 days). Clinical and electrophysiological evaluations were performed before and after treatment. Following IVIg treatment there was no significant improvement in clinical deficit. However, there was a significant and persistent decrease in the Rankin scale score and an improvement in the demyelinating feature on nerve conduction studies. Our findings suggest that IVIg had small but detectable beneficial effects on diabetic patients with CIDP and a high degree of axonal damage.
- Subjects
DIABETES; IMMUNOGLOBULINS; PEOPLE with diabetes; POLYNEUROPATHIES; DEMYELINATION; NEUROLOGY
- Publication
Journal of Neurology, 2002, Vol 249, Issue 6, p719
- ISSN
0340-5354
- Publication type
Article
- DOI
10.1007/s00415-002-0698-0